FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joerg Daumann

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Physiology

Activities & Behaviors

Psychomotor Performance

Procedures

Brain Mapping

Co-author Network

Publications

TOP 3
Benjamin Becker; Katja Bender; Euphrosyne Gouzoulis-Mayfrank; Christoph Kabbasch; Philip Koester; Daniel Wagner; Joerg Daumann
Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.
Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Philip Koester; Joerg Daumann
A prospective study of learning, memory, and executive function in new MDMA users.
P Koester; Marc Tittgemeyer; D Wagner; B Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Cortical thinning in amphetamine-type stimulant users.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joerg Daumann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Benjamin Becker; Katja Bender; Euphrosyne Gouzoulis-Mayfrank; Christoph Kabbasch; Philip Koester; Daniel Wagner; Joerg Daumann
Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.
Psychopharmacology 2013;225(4):923-34.
2013: Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Philip Koester; Joerg Daumann
A prospective study of learning, memory, and executive function in new MDMA users.
Addiction (Abingdon, England) 2013;108(1):136-45.
2012: P Koester; Marc Tittgemeyer; D Wagner; B Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Cortical thinning in amphetamine-type stimulant users.
Neuroscience 2012;221():182-92.
2012: Thomas Schnell; Joerg Daumann; Euphrosyne Gouzoulis-Mayfrank; Alexandra Kleiman; Benjamin Becker
Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL.
Schizophrenia research 2012;138(2-3):183-7.
2011: Joerg Daumann; Philip Koester; Benjamin Becker; Daniel Wagner; Davide Imperati; Euphrosyne Gouzoulis-Mayfrank; Marc Tittgemeyer
Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry.
NeuroImage 2011;54(2):794-801.
2011: Jens Kuhn; Doris Lenartz; Mohammad Maarouf; C Bartsch; Joerg Daumann; Stefan Hunsche; D Huys; Joachim Klosterkötter; Christiane Woopen; Volker Sturm
Clinical effectiveness of unilateral deep brain stimulation in Tourette syndrome.
Translational psychiatry 2011;1():e52.
2010: Joerg Daumann; D Wagner; Karsten Heekeren; Anna Neukirch; C M Thiel; Euphrosyne Gouzoulis-Mayfrank
Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis.
Journal of psychopharmacology (Oxford, England) 2010;24(10):1515-24.
2010: Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Interactions between specific parameters of cannabis use and verbal memory.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(6):871-6.
2010: Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Joerg Daumann
The impact of early-onset cannabis use on functional brain correlates of working memory.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(6):837-45.
2010: Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Joerg Daumann
Altered parahippocampal functioning in cannabis users is related to the frequency of use.
Psychopharmacology 2010;209(4):361-74.
2010: T Schnell; K Neisius; Joerg Daumann; Euphrosyne Gouzoulis-Mayfrank
[Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city].
Der Nervenarzt 2010;81(3):323-8.
2010: Wolfgang Huff; Doris Lenartz; Michael Schormann; Sun-Hee Lee; Jens Kuhn; Athanasios Koulousakis; Juergen Mai; Joerg Daumann; Mohammad Maarouf; Joachim Klosterkötter; Volker Sturm
Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year.
Clinical neurology and neurosurgery 2010;112(2):137-43.
2009: Thomas Schnell; Dagmar Koethe; Joerg Daumann; Euphrosyne Gouzoulis-Mayfrank
The role of cannabis in cognitive functioning of patients with schizophrenia.
Psychopharmacology 2009;205(1):45-52.
2009: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.
Dialogues in clinical neuroscience 2009;11(3):305-17.
2008: Joerg Daumann; Karsten Heekeren; Anna Neukirch; Christiane M Thiel; Walter Möller-Hartmann; Euphrosyne Gouzoulis-Mayfrank
Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis.
Psychopharmacology 2008;200(4):573-83.
2008: Knut Schnell; Karsten Heekeren; Joerg Daumann; Thomas Schnell; Ralph Schnitker; Walter Möller-Hartmann; Euphrosyne Gouzoulis-Mayfrank
Correlation of passivity symptoms and dysfunctional visuomotor action monitoring in psychosis.
Brain : a journal of neurology 2008;131(Pt 10):2783-97.
2008: Karsten Heekeren; Joerg Daumann; Anna Neukirch; Carsten Stock; Wolfram Kawohl; Christine Norra; Till D Waberski; Euphrosyne Gouzoulis-Mayfrank
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Psychopharmacology 2008;199(1):77-88.
2007: Euphrosyne Gouzoulis-Mayfrank; Maryam Balke; Soulmaz Hajsamou; Stephan Ruhrmann; Frauke Schultze-Lutter; Joerg Daumann; Karsten Heekeren
Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives.
Schizophrenia research 2007;97(1-3):35-42.
2007: Karsten Heekeren; Anna Neukirch; Joerg Daumann; Martina Stoll; Maja Obradovic; Karl-Artur Kovar; Mark A Geyer; Euphrosyne Gouzoulis-Mayfrank
Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
Journal of psychopharmacology (Oxford, England) 2007;21(3):312-20.
2007: Andy C Parrott; Raffaella M Milani; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(8):959-68.
2007: Knut Schnell; Karsten Heekeren; Ralf Schnitker; Joerg Daumann; Jochen Weber; Volker Hesselmann; Walter Möller-Hartmann; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
An fMRI approach to particularize the frontoparietal network for visuomotor action monitoring: Detection of incongruence between test subjects' actions and resulting perceptions.
NeuroImage 2007;34(1):332-41.
2007: Knut Schnell; T Dietrich; Ralph Schnitker; Joerg Daumann; Stephan Herpertz
Processing of autobiographical memory retrieval cues in borderline personality disorder.
Journal of affective disorders 2007;97(1-3):253-9.
2006: Joerg Daumann; Bianca Till; Thomas Fischermann; Markus Rezk; Euphrosyne Gouzoulis-Mayfrank
Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Journal of psychopharmacology (Oxford, England) 2006;20(2):236-44.
2006: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Journal of psychopharmacology (Oxford, England) 2006;20(2):188-93.
2006: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Addiction (Abingdon, England) 2006;101(3):348-61.
2006: Euphrosyne Gouzoulis-Mayfrank; Karsten Heekeren; Anna Neukirch; Martina Stoll; Carsten Stock; Joerg Daumann; Maja Obradovic; Karl-Artur Kovar
Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(2):431-41.
2005: Joerg Daumann; Thomas Fischermann; Karsten Heekeren; Katharina Henke; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Psychopharmacology 2005;180(4):607-11.
2005: Euphrosyne Gouzoulis-Mayfrank; Thomas Fischermann; Markus Rezk; Bastian Thimm; Gernot Hensen; Joerg Daumann
Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
Drug and alcohol dependence 2005;78(3):317-23.
2004: Joerg Daumann; Thomas Fischermann; Karsten Heekeren; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Biological psychiatry 2004;56(5):349-55.
2004: Joerg Daumann; Thomas Fischermann; Ulrich Pilatus; Armin Thron; Walter Moeller-Hartmann; Euphrosyne Gouzoulis-Mayfrank
Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.
Neuroscience letters 2004;362(2):113-6.
2004: Karsten Heekeren; Joerg Daumann; Mark A Geyer; Euphrosyne Gouzoulis-Mayfrank
Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users.
Psychopharmacology 2004;173(3-4):418-24.
2004: Joerg Daumann; Gernot Hensen; Bastian Thimm; Markus Rezk; Bianca Till; Euphrosyne Gouzoulis-Mayfrank
Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
Psychopharmacology 2004;173(3-4):398-404.
2003: Joerg Daumann; Ralph Schnitker; Jürgen Weidemann; Knut Schnell; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
Neuroreport 2003;14(15):1983-7.
2003: Euphrosyne Gouzoulis-Mayfrank; Bastian Thimm; Markus Rezk; Gernot Hensen; Joerg Daumann
Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(5):819-27.
2003: Joerg Daumann; Bruno Fimm; Klaus Willmes; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
Brain research. Cognitive brain research 2003;16(3):479-87.
2002: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann; Henning Sass
[Chronic neurotoxic damage in ecstasy (MDMA) users. Review of the current state of research].
Der Nervenarzt 2002;73(5):405-21.
2002: Euphrosyne Gouzoulis-Mayfrank; Steffanie Becker; Susanne Pelz; Frank Tuchtenhagen; Joerg Daumann
Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?
Biological psychiatry 2002;51(9):766-9.
2000: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann; Frank Tuchtenhagen; Susanne Pelz; Steffanie Becker; Hanns Jürgen Kunert; Bruno Fimm; Henning Sass
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Journal of neurology, neurosurgery, and psychiatry 2000;68(6):719-25.
2000: Frank Tuchtenhagen; Joerg Daumann; Christine Norra; René Gobbelé; Steffanie Becker; Susanne Pelz; Henning Sass; Helmut Buchner; Euphrosyne Gouzoulis-Mayfrank
High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(6):608-17.